In the present study, we tested the effect of OS (oxidative stress) inhibition in rats fed on an FRD [fructose-rich diet; 10% (w/v) in drinking water] for 3 weeks. Normal adult male rats received a standard CD (commercial diet) or an FRD without or with an inhibitor of NADPH oxidase, APO (apocynin; 5 mM in drinking water; CD-APO and FRD-APO). We thereafter measured plasma OS and metabolic-endocrine markers, AAT (abdominal adipose tissue) mass and cell size, FA (fatty acid) composition (content and release), OS status, LEP (leptin) and IRS (insulin receptor substrate)-1/IRS-2 mRNAs, ROS (reactive oxygen species) production, NADPH oxidase activity and LEP release by isolated AAT adipocytes. FRD-fed rats had larger AAT mass without changes in body weight, and higher plasma levels of TAG (triacylglycerol), FAs, TBARS (thiobarbituric acid-reactive substance) and LEP. Although no significant changes in glucose and insulin plasma levels were observed in these animals, their HOMA-IR (homoeostasis model assessment of insulin resistance) values were significantly higher than those of CD. The AAT from FRD-fed rats had larger adipocytes, higher saturated FA content, higher NADPH oxidase activity, greater ROS production, a distorted FA content/release pattern, lower insulin sensitivity together with higher and lower mRNA content of LEP and IRS-1-/2 respectively, and released a larger amount of LEP. The development of all the clinical, OS, metabolic, endocrine and molecular changes induced by the FRD were significantly prevented by APO co-administration. The fact that APO treatment prevented both changes in NADPH oxidase activity and the development of all the FRD-induced AAT dysfunctions in normal rats strongly suggests that OS plays an important role in the FRD-induced MS (metabolic syndrome) phenotype.
Skip Nav Destination
Article navigation
Research Article|
March 26 2013
Antioxidant treatment prevents the development of fructose-induced abdominal adipose tissue dysfunction
Juan Pablo Fariña;
Juan Pablo Fariña
1
*CENEXA (UNLP-CONICET LA PLATA, PAHO/WHO Collaborating Centre for Diabetes), National University of La Plata School of Medicine, La Plata, Argentina
Search for other works by this author on:
María Elisa García;
María Elisa García
1
*CENEXA (UNLP-CONICET LA PLATA, PAHO/WHO Collaborating Centre for Diabetes), National University of La Plata School of Medicine, La Plata, Argentina
Search for other works by this author on:
Ana Alzamendi;
Ana Alzamendi
†Neuroendocrine Unit, IMBICE (CICPBA-CONICET LA PLATA) La Plata, Argentina
Search for other works by this author on:
Andrés Giovambattista;
Andrés Giovambattista
†Neuroendocrine Unit, IMBICE (CICPBA-CONICET LA PLATA) La Plata, Argentina
Search for other works by this author on:
Carlos Alberto Marra;
Carlos Alberto Marra
‡INIBIOLP (UNLP-CONICET LA PLATA), National University of La Plata School of Medicine, La Plata, Argentina
Search for other works by this author on:
Eduardo Spinedi;
Eduardo Spinedi
†Neuroendocrine Unit, IMBICE (CICPBA-CONICET LA PLATA) La Plata, Argentina
Search for other works by this author on:
Juan José Gagliardino
*CENEXA (UNLP-CONICET LA PLATA, PAHO/WHO Collaborating Centre for Diabetes), National University of La Plata School of Medicine, La Plata, Argentina
Correspondence: Dr Juan J. Gagliardino (email [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
August 30 2012
Revision Received:
November 29 2012
Accepted:
February 06 2013
Accepted Manuscript online:
February 06 2013
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© The Authors Journal compilation © 2013 Biochemical Society
2013
Clin Sci (Lond) (2013) 125 (2): 87–97.
Article history
Received:
August 30 2012
Revision Received:
November 29 2012
Accepted:
February 06 2013
Accepted Manuscript online:
February 06 2013
Citation
Juan Pablo Fariña, María Elisa García, Ana Alzamendi, Andrés Giovambattista, Carlos Alberto Marra, Eduardo Spinedi, Juan José Gagliardino; Antioxidant treatment prevents the development of fructose-induced abdominal adipose tissue dysfunction. Clin Sci (Lond) 1 July 2013; 125 (2): 87–97. doi: https://doi.org/10.1042/CS20120470
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |